Molecular characterisation of a panel of human ovarian carcinoma xenografts

被引:17
|
作者
Codegoni, AM
Nicoletti, MI
Buraggi, G
Valoti, G
Giavazzi, R
D'Incalci, M
Landoni, F
Maneo, A
Broggini, M
机构
[1] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy
[2] Mario Negri Inst Pharmacol Res, I-24125 Bergamo, Italy
[3] Univ Milan, Osped San Gerardo, Monza, MI, Italy
关键词
ovarian cancer; xenografts; cell cycle proteins; DNA repair; drug resistance;
D O I
10.1016/S0959-8049(98)00075-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a panel of 16 human ovarian tumours transplanted in nude mice, the expression of genes involved in cell cycle regulation and in response to drug treatment were characterised. In the 16 tumours analysed we could not detect overexpression of Erb-B2 oncogene while expression of MDR1 mRNA was not detected in 11/15 samples and was low in 4/15 tumours. Only three tumours had mutations in the p53 gene exons 5-8 and one of these mutations did not result in any amino acid alteration. The levels of mRNA for cyclins A, D1 and E were heterogeneous with some tumours expressing high levels and others not expressing them at all. The same was found for the cyclin dependent kinases (CDK) CDK2 and CDK4 and for CDK inhibitors P21/WAF1, p27/KIP1 and p16/CDKN2. Two genes belonging to the nucleotide excision repair, ERCC1 and ERCC3 were detectable in all the samples examined, as were the genes MGMT and MAG, also involved in DNA repair. The data indicate a heterogeneity in the expression of genes considered to be involved in the cellular responses to cytotoxic drug treatment and indicate the possibility of using these tumour models to test specifically molecules with a defined mechanism of action. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1432 / 1438
页数:7
相关论文
共 50 条
  • [41] Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts
    Kolfschoten, GM
    Hulscher, TM
    Pinedo, HM
    Boven, E
    BRITISH JOURNAL OF CANCER, 2000, 83 (07) : 921 - 927
  • [42] Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts
    G M Kolfschoten
    T M Hulscher
    H M Pinedo
    E Boven
    British Journal of Cancer, 2000, 83 : 921 - 927
  • [43] Expression of β-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-anticancer drug screen:: Correlation with sensitivity to microtubule active agents
    Nicoletti, MI
    Valoti, G
    Giannakakou, P
    Zhan, ZR
    Kim, JH
    Lucchini, V
    Landoni, F
    Mayo, JG
    Giavazzi, R
    Fojo, T
    CLINICAL CANCER RESEARCH, 2001, 7 (09) : 2912 - 2922
  • [44] Molecular stratification of ovarian carcinoma
    Herrington, C. Simon
    JOURNAL OF PATHOLOGY, 2023, 261 (SUPPL1): : S9 - S9
  • [45] Molecular Biomarkers in Ovarian Carcinoma
    Yazici, Hulya
    Sukruoglu, Ozge
    Kilic, Seda
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2016, 31 (04): : 149 - 159
  • [46] Molecular carcinogenesis of ovarian carcinoma
    不详
    PATHOLOGY RESEARCH AND PRACTICE, 2005, 201 (03) : 214 - 214
  • [47] INTRAPERITONEAL AND SUBCUTANEOUS XENOGRAFTS OF HUMAN OVARIAN-CARCINOMA IN NUDE-MICE AND THEIR POTENTIAL IN EXPERIMENTAL-THERAPY
    MASSAZZA, G
    TOMASONI, A
    LUCCHINI, V
    ALLAVENA, P
    ERBA, E
    COLOMBO, N
    MANTOVANI, A
    DINCALCI, M
    MANGIONI, C
    GIAVAZZI, R
    INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (03) : 494 - 500
  • [48] Magnetic resonance imaging-based prospective detection of intraperitoneal human ovarian carcinoma xenografts treatment response
    Klostergaard, J
    Auzenne, E
    Ghosh, S
    Farquhar, D
    Rivera, B
    Price, RE
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 : 111 - 117
  • [49] Hyaluronic acid-paclitaxel: Antitumor efficacy against CD44(+) human ovarian carcinoma xenografts
    Auzenne, Edmond
    Ghosh, Sukhen C.
    Khodadadian, Mojgan
    Rivera, Belinda
    Farquhar, David
    Price, Roger E.
    Ravoori, Murali
    Kundra, Vikas
    Freedman, Ralph S.
    Klostergaard, Jim
    NEOPLASIA, 2007, 9 (06): : 479 - 486
  • [50] Ecteinascidin-743, a new marine natural product with potent antitumor activity on human ovarian carcinoma xenografts
    Valoti, G
    Nicoletti, MI
    Pellegrino, A
    Jimeno, J
    Hendriks, H
    D'Incalci, M
    Faircloth, G
    Giavazzi, R
    CLINICAL CANCER RESEARCH, 1998, 4 (08) : 1977 - 1983